http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2941454-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
filingDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5f48c16da3219ca2bcee65c02f1815c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58863898bc5e411846d044a8970f8693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04160a4edecd396d70d290128b8f8644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_911758092bec29a68718bfdffa55de8a
publicationDate 2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2941454-B1
titleOfInvention PROCESS FOR THE SYNTHESIS OF (1S, 2R) -MILNACIPRAN
abstract The present invention relates to a process for the synthesis of a pharmaceutically acceptable acid addition salt of (1S,2R)-milnacipran comprising the following successive steps: (a) reaction of phenylacetonitrile and (R)-epichlorohydrin in the presence of a base containing an alkali metal, followed by a basic treatment, then an acid treatment to give a lactone (b) reacting said lactone with MNEt , where M represents an alkali metal, or with NHEt in the presence of a Lewis acid-amine complex, to give an amide-alcohol (c) reacting said amide-alcohol with thionyl chloride to give a chlorinated amide (d) reacting said chlorinated amide with a phthalimide salt to give a phthalimide derivative ( e) hydrolysis of the phthalimide group of said phthalimide derivative to give (1S,2R)-milnacipran, and (f) salification of (1S,2R)-milnacipran in a suitable solvent system in the presence of a pharmaceutically acceptable acid.
priorityDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8794

Total number of triples: 26.